LIVE@Home.Path:为居家痴呆患者及照护者创新临床路径的混合方法阶梯楔形随机对照试验方案
该方案描述LIVE@Home.Path试验的基本原理、开发、可行性测试与实施过程;试验为为期2年、多中心、混合方法、阶梯楔形随机对照设计,计划从挪威3个市镇招募315对居家痴呆患者与照护者;所有配对均接受干预,接受时机由随机决定,对照组为等待干预的配对。
要点
- 干预核心为市政协调员,在6个月干预期内定期联系配对,促进学习、创新、志愿服务与赋权。
- 主要结局为资源利用,以RUD工具和RSS测量,兼顾照护时间与照护者负担。
- 试验注册号NCT04043364,2019年3月15日注册。
核心结论
- 研究团队预期LIVE路径相较常规照护具有成本效果,并支持高质量的居家独立生活。
研究设计与样本
- LIVE@Home.Path为为期2年、多中心、混合方法、阶梯楔形随机对照试验,计划纳入315对居家痴呆患者与照护者。
- 招募来自挪威3个市镇;阶梯楔形随机化使所有配对均接受干预,接受时机由随机决定,对照组为等待干预的配对。
关键数值与推荐
- 干预为期6个月,参与者被分配至市政协调员,协调员负责定期联系配对以促进L:Learning、I:Innovation、V:Volunteering、E:Empowerment。
- 主要结局为资源利用,以Resource Utilization in Dementia(RUD)工具和Relative Stress Scale(RSS)测量。
临床怎么用
- 干预为多组分,与用户代表、研究人员和利益相关者共同开发,以满足国家Dementia Plan 2020要求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The global health challenge of dementia is exceptional in size, cost and impact. It is the only top ten cause of death that cannot be prevented, cured or substantially slowed, leaving disease management, caregiver support and service innovation as the main targets for reduction of disease burden. Institutionalization of persons with dementia is common in western countries, despite patients preferring to live longer at home, supported by caregivers. Such complex health challenges warrant multicomponent interventions thoroughly implemented in daily clinical practice. This article describes the rationale, development, feasibility testing and implementation process of the LIVE@Home.Path trial. METHODS: The LIVE@Home.Path trial is a 2-year, multicenter, mixed-method, stepped-wedge randomized controlled trial, aiming to include 315 dyads of home-dwelling people with dementia and their caregivers, recruited from 3 municipalities in Norway. The stepped-wedge randomization implies that all dyads receive the intervention, but the timing is determined by randomization. The control group constitutes the dyads waiting for the intervention. The multicomponent intervention was developed in collaboration with user-representatives, researchers and stakeholders to meet the requirements from the national Dementia Plan 2020. During the 6-month intervention period, the participants will be allocated to a municipal coordinator, the core feature of the intervention, responsible for regular contact with the dyads to facilitate L: Learning, I: Innovation, V: Volunteering and E: Empowerment (LIVE). The primary outcome is resource utilization. This is measured by the Resource Utilization in Dementia (RUD) instrument and the Relative Stress Scale (RSS), reflecting that resource utilization is more than the actual time required for caring but also how burdensome the task is experienced by the caregiver. DISCUSSION: We expect the implementation of LIVE to lead to a pathway for dementia treatment and care which is cost-effective, compared to treatment as usual, and will support high-quality independent living, at home. TRIAL REGISTRATION: ClinicalTrials.gov: NCT04043364. Registered on 15 March 2019.
引用
- Husebo BS, Allore H, Achterberg W, et al. LIVE@Home.Path-innovating the clinical pathway for home-dwelling people with dementia and their caregivers: study protocol for a mixed-method, stepped-wedge, randomized controlled trial. Trials. 2020. PMID: 32517727. doi:10.1186/s13063-020-04414-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。